Jon C Emery
Overview
Explore the profile of Jon C Emery including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Emery J, Dodd P, Banu S, Frascella B, Garden F, Horton K, et al.
Elife
. 2023 Dec;
12.
PMID: 38109277
Background: Individuals with bacteriologically confirmed pulmonary tuberculosis (TB) disease who do not report symptoms (subclinical TB) represent around half of all prevalent cases of TB, yet their contribution to ()...
2.
Horton K, Richards A, Emery J, Esmail H, Houben R
Proc Natl Acad Sci U S A
. 2023 Nov;
120(47):e2221186120.
PMID: 37963250
Traditional understanding of the risk of progression from () infection to tuberculosis (TB) overlooks diverse presentations across a spectrum of disease. We developed a deterministic model of infection and minimal...
3.
Scarponi D, Clark R, Weerasuriya C, Emery J, Houben R, White R, et al.
medRxiv
. 2023 Apr;
PMID: 37090535
Background: Mathematical modelling has been used extensively to estimate the potential impact of new tuberculosis vaccines, with the majority of existing models assuming that individuals with Mycobacterium tuberculosis (Mtb) infection...
4.
Richards A, Sossen B, Emery J, Horton K, Heinsohn T, Frascella B, et al.
Lancet Glob Health
. 2023 Mar;
11(5):e684-e692.
PMID: 36966785
Background: Prevalence surveys show a substantial burden of subclinical (asymptomatic but infectious) tuberculosis, from which individuals can progress, regress, or even persist in a chronic disease state. We aimed to...
5.
Schwalb A, Emery J, Dale K, Horton K, Ugarte-Gil C, Houben R
Am J Epidemiol
. 2023 Feb;
192(12):1937-1943.
PMID: 36749011
A key metric in tuberculosis epidemiology is the annual risk of infection (ARI), which is usually derived from tuberculin skin test (TST) and interferon-γ release assay (IGRA) prevalence surveys carried...
6.
Emery J, Richards A, Dale K, McQuaid C, White R, Denholm J, et al.
Proc Biol Sci
. 2021 Jan;
288(1943):20201635.
PMID: 33467995
: it is widely assumed that individuals with () infection remain at lifelong risk of tuberculosis (TB) disease. However, there is substantial evidence that self-clearance of infection can occur. We...
7.
Frascella B, Richards A, Sossen B, Emery J, Odone A, Law I, et al.
Clin Infect Dis
. 2020 Sep;
73(3):e830-e841.
PMID: 32936877
While it is known that a substantial proportion of individuals with tuberculosis disease (TB) present subclinically, usually defined as bacteriologically-confirmed but negative on symptom screening, considerable knowledge gaps remain. Our...
8.
Emery J, Russell T, Liu Y, Hellewell J, Pearson C, Knight G, et al.
Elife
. 2020 Aug;
9.
PMID: 32831176
A key unknown for SARS-CoV-2 is how asymptomatic infections contribute to transmission. We used a transmission model with asymptomatic and presymptomatic states, calibrated to data on disease onset and test...
9.
Houben R, Esmail H, Emery J, Joslyn L, McQuaid C, Menzies N, et al.
Lancet Respir Med
. 2019 Mar;
7(3):199-201.
PMID: 30823971
No abstract available.